##gff-version 3
##sequence-region Q96J92 1 1243
Q96J92	UniProtKB	Chain	1	1243	.	.	.	ID=PRO_0000086824;Note=Serine/threonine-protein kinase WNK4	
Q96J92	UniProtKB	Domain	174	432	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159	
Q96J92	UniProtKB	Nucleotide binding	254	257	.	.	.	Note=ATP;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9H4A3	
Q96J92	UniProtKB	Active site	321	321	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JIH7	
Q96J92	UniProtKB	Binding site	184	184	.	.	.	Note=ATP%3B via amide nitrogen;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9H4A3	
Q96J92	UniProtKB	Binding site	304	304	.	.	.	Note=ATP;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9H4A3	
Q96J92	UniProtKB	Modified residue	97	97	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q96J92	UniProtKB	Modified residue	331	331	.	.	.	Note=Phosphoserine%3B by autocatalysis;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JIH7	
Q96J92	UniProtKB	Modified residue	335	335	.	.	.	Note=Phosphoserine%3B by autocatalysis;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JIH7	
Q96J92	UniProtKB	Modified residue	1035	1035	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TPK6	
Q96J92	UniProtKB	Modified residue	1217	1217	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q80UE6	
Q96J92	UniProtKB	Cross-link	157	157	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	175	175	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	186	186	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	226	226	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	241	241	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	328	328	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	387	387	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	393	393	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	450	450	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	454	454	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	1010	1010	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	1144	1144	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	1157	1157	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Cross-link	1158	1158	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23576762;Dbxref=PMID:23576762	
Q96J92	UniProtKB	Alternative sequence	1	228	.	.	.	ID=VSP_050648;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96J92	UniProtKB	Alternative sequence	229	264	.	.	.	ID=VSP_050649;Note=In isoform 2. QHPNIVRFYDSWKSVLRGQVCIVLVTELMTSGTLKT->MRRRQQGAAGGNFPVGGSFPEDVSPHQDSGYAPSPR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96J92	UniProtKB	Alternative sequence	828	1210	.	.	.	ID=VSP_050650;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96J92	UniProtKB	Alternative sequence	1145	1165	.	.	.	ID=VSP_050652;Note=In isoform 3. HLSEVETLQTLQKKEIEDLYS->PFHALRASSGTCQRWKHYRHY;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96J92	UniProtKB	Alternative sequence	1166	1243	.	.	.	ID=VSP_050653;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96J92	UniProtKB	Alternative sequence	1233	1243	.	.	.	ID=VSP_050651;Note=In isoform 2. GVTFAGDVGRM->EAGQRPGKLWLRATVQLRVWGLELRRKEMMGRNPKLGAAPNP;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q96J92	UniProtKB	Natural variant	434	434	.	.	.	ID=VAR_041330;Note=In an ovarian mucinous carcinoma sample%3B somatic mutation. E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q96J92	UniProtKB	Natural variant	562	562	.	.	.	ID=VAR_017588;Note=In PHA2B%3B impaired interaction with KLHL3. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11498583,ECO:0000269|PubMed:23387299,ECO:0000269|PubMed:23576762;Dbxref=dbSNP:rs137853093,PMID:11498583,PMID:23387299,PMID:23576762	
Q96J92	UniProtKB	Natural variant	564	564	.	.	.	ID=VAR_017589;Note=In PHA2B%3B impaired interaction with KLHL3. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11498583,ECO:0000269|PubMed:23453970;Dbxref=dbSNP:rs137853094,PMID:11498583,PMID:23453970	
Q96J92	UniProtKB	Natural variant	565	565	.	.	.	ID=VAR_017590;Note=In PHA2B%3B impaired interaction with KLHL3. Q->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11498583,ECO:0000269|PubMed:23387299,ECO:0000269|PubMed:23576762;Dbxref=dbSNP:rs137853092,PMID:11498583,PMID:23387299,PMID:23576762	
Q96J92	UniProtKB	Natural variant	601	601	.	.	.	ID=VAR_061748;Note=A->S;Dbxref=dbSNP:rs55781437	
Q96J92	UniProtKB	Natural variant	677	677	.	.	.	ID=VAR_051685;Note=R->W;Dbxref=dbSNP:rs9896991	
Q96J92	UniProtKB	Natural variant	813	813	.	.	.	ID=VAR_041331;Note=P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q96J92	UniProtKB	Natural variant	961	961	.	.	.	ID=VAR_051686;Note=P->S;Dbxref=dbSNP:rs2290041	
Q96J92	UniProtKB	Natural variant	992	992	.	.	.	ID=VAR_041332;Note=In a metastatic melanoma sample%3B somatic mutation. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q96J92	UniProtKB	Natural variant	1013	1013	.	.	.	ID=VAR_041333;Note=L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q96J92	UniProtKB	Natural variant	1185	1185	.	.	.	ID=VAR_017591;Note=In PHA2B. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11498583;Dbxref=dbSNP:rs137853095,PMID:11498583	
Q96J92	UniProtKB	Sequence conflict	525	525	.	.	.	Note=R->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q96J92	UniProtKB	Helix	562	564	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4CHB	
